shuterstock-138839393

Lightspring / Shutterstock.com

27 November 2014Ranjna Mehta-Dutt and Neha Srivastava

Biologics in India: bridging the gap

Section 10(4)(ii)(D) of India’s Patents Act, 1970 mandates the disclosure of the source and geographical origin of biological material whenever it’s mentioned in a patent specification but not sufficiently described in it or made available to the public.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Attorney v examiner: Navigating patenting's AI tools ‘arms race’

Unified Patent Court: The cases, the numbers and what the future holds

Second chances: Brazil’s bid to revitalise the country’s healthcare system

Why the US non-competes ban has riled Big Pharma

Life sciences cases at the UPC will surely rise, but is the court prepared?

HDT Bio and Emcure resolve $950m trade secrets 'misunderstanding'

Moderna’s COVID-19 pledge dilemma

Teva targets Indian pharma firm over inhaler patents